Healthcare

PRODUCTS

  • Getting a novel therapy through the clinical development process to approval is complicated. Unearth how to advance novel medical therapies from Phase I-III clinical development to market with confidence.

  • Turning Data into Insights

    At Catalyst Flex, we understand that clean data is the foundation of successful analyses. We are an accredited Medidata Partner and certified study builders in multiple platforms.

  • Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.

  • Providing around-the-clock support, enabled by at least two QPs per assignment, delivering full continuity, and reduced risk.

  • Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:

    • Narrow I/E criteria that don’t translate into real-world patients
    • Sites with limited behavioral health infrastructure
    • Lack of patient trust and trial awareness in psychiatric populations
    • Professional patients
    • Rating scales aren’t used in clinical practices

    But what if recruitment didn’t have to start with a gamble?

WHITE PAPERS AND CASE STUDIES

NEWS